Barinthus Biotherapeutics plc (BRNS)
NASDAQ: BRNS · Real-Time Price · USD
0.945
+0.046 (5.12%)
Nov 21, 2024, 11:09 AM EST - Market open

Barinthus Biotherapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Revenue
14.970.844.70.274.826.85
Revenue Growth (YoY)
106.21%-98.21%16580.22%-94.44%-29.57%-
Cost of Revenue
45.0944.8742.3520.3714.3929.84
Gross Profit
-30.12-44.072.35-20.1-9.57-23
Selling, General & Admin
40.5539.796.4725.1210.482.67
Research & Development
-7.22-3.46-1.24-4-3.28-2.98
Operating Expenses
32.3336.335.2321.127.2-0.31
Operating Income
-62.45-80.4-2.87-41.22-16.77-22.69
Interest Expense
-0.05-0.03-0.02-2.67-3.6-0.13
Interest & Investment Income
2.612.883.10-0.04
Currency Exchange Gain (Loss)
---0.210.45-
Other Non Operating Income (Expenses)
0.821.080.576.332.080.08
EBT Excluding Unusual Items
-59.07-76.470.78-37.35-17.84-22.7
Gain (Loss) on Sale of Assets
-----0
Other Unusual Items
0.32-0.060.07-13.79--
Pretax Income
-58.75-76.520.85-51.14-17.84-22.7
Income Tax Expense
-0.87-3.08-4.47-0.030.1-
Earnings From Continuing Operations
-57.88-73.455.32-51.11-17.93-22.7
Minority Interest in Earnings
0.060.10.020.250.231.97
Net Income
-57.83-73.355.34-50.87-17.71-20.73
Net Income to Common
-57.83-73.355.34-50.87-17.71-20.73
Shares Outstanding (Basic)
3938372680
Shares Outstanding (Diluted)
3938382680
Shares Change (YoY)
2.31%0.57%47.40%227.59%33580.72%-
EPS (Basic)
-1.48-1.910.14-1.96-2.24-883.28
EPS (Diluted)
-1.49-1.910.14-1.96-2.24-883.28
Free Cash Flow
-62.09-56.34-20.57-33.73-11.32-18.81
Free Cash Flow Per Share
-1.59-1.47-0.54-1.30-1.43-801.48
Gross Margin
-201.19%-5.26%--198.42%-
Operating Margin
-417.20%-10024.69%-6.43%-15380.60%-347.79%-331.46%
Profit Margin
-386.31%-9145.51%11.95%-18979.48%-367.27%-302.84%
Free Cash Flow Margin
-414.79%-7024.69%-46.01%-12585.45%-234.83%-274.80%
EBITDA
-59.84-78.17-1.75-40.82-16.56-22.52
EBITDA Margin
---3.92%---
D&A For EBITDA
2.612.231.120.40.210.17
EBIT
-62.45-80.4-2.87-41.22-16.77-22.69
EBIT Margin
---6.43%---
Revenue as Reported
14.970.844.70.274.826.85
Source: S&P Capital IQ. Standard template. Financial Sources.